Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Overview of annual performance metrics for index funds highlights consistency and risk-adjusted returns to inform choices.
21,807 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
An AI forecast from Claude points to multix gains for XRP, Solana, and Dogecoin by 2026. The predictions hinge on ado...
Bitcoin’s calm price action has persisted through February 2026, but traders warn the lull may be masking fading ETF ...
Debt worries surround a proposed $1.5 trillion boost to the Pentagon budget, drawing pushback from fiscal hawks and r...
Georgia lawmakers revived a constitutional amendment aimed at protecting LIHTC properties from steep property tax hik...
A viral Reddit post argues you can reach a $1.2 million nest egg by age 67 with no additional contributions, starting...
Financial recovery goes hand in hand with personal recovery. This guide shows how to budget for treatment, tackle deb...
Former President Bill Clinton testified in a congressional deposition in Chappaqua, defending his past relationship w...
A strong pharma dividend stock could be a powerful component of a retirement plan. Learn how to choose, invest, and c...
Private and public sector leaders warn that Iran is expanding its AI-enabled cyber toolkit, raising the risk to banks...
Hidden Road's NSCC integration marks a milestone for Ripple's XRP ecosystem as RLUSD grows, boosting liquidity and in...
Vitalik Buterin unveils Sanctuary Tech, hinting at a new endgame for Ethereum. The idea arrives as macro volatility w...